Cellink Financial Statements From 2010 to 2024
| CLLKF Stock | USD 2.93 0.08 2.81% |
Check Cellink AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellink AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . Cellink financial statements analysis is a perfect complement when working with Cellink AB Valuation or Volatility modules.
Cellink |
Cellink AB Company Current Valuation Analysis
Cellink AB's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Cellink AB Current Valuation | 973.88 M |
Most of Cellink AB's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cellink AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Cellink AB has a Current Valuation of 973.88 M. This is 93.22% lower than that of the Healthcare sector and 92.16% lower than that of the Medical Devices industry. The current valuation for all United States stocks is 94.14% higher than that of the company.
Cellink AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cellink AB's current stock value. Our valuation model uses many indicators to compare Cellink AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cellink AB competition to find correlations between indicators driving Cellink AB's intrinsic value. More Info.Cellink AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cellink AB's earnings, one of the primary drivers of an investment's value.About Cellink AB Financial Statements
Cellink AB stakeholders use historical fundamental indicators, such as Cellink AB's revenue or net income, to determine how well the company is positioned to perform in the future. Although Cellink AB investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cellink AB's assets and liabilities are reflected in the revenues and expenses on Cellink AB's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cellink AB. Please read more on our technical analysis and fundamental analysis pages.
BICO Group AB operates as a bio convergence company in North America, Europe, Asia, and internationally. BICO Group AB was founded in 2016 and is based in Gothenburg, Sweden. Bico Group is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Cellink Pink Sheet
Cellink AB financial ratios help investors to determine whether Cellink Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cellink with respect to the benefits of owning Cellink AB security.